Health Tip: Worried About Excessive Sweating?

(HealthDay News) -- Excessive sweating, medically called hyperhidrosis, usually affects any combination of the underarms, palms, soles or groin.

Health Tip: Operate a Slow Cooker Safely

(HealthDay News) -- A slow cooker is a handy tool that can cook all day long so you can enjoy a healthy meal without a lot of preparation.

Chronic Exposure to Airplane Noise Might Harm the Heart: Study

WEDNESDAY, Oct. 9 (HealthDay News) -- People who put up with the constant roar of aircraft overhead may be at higher risk for heart disease, two new studies suggest.

Early Puberty Tied to Higher Odds of Substance Use in Teens: Survey

WEDNESDAY, Oct. 9 (HealthDay News) -- Teens who began puberty at an early age are more likely to experiment with cigarettes, alcohol and marijuana, researchers report.

Efforts to Improve Intensive-Care Outcomes Produce Mixed Results

WEDNESDAY, Oct. 9 (HealthDay News) -- Three different efforts to improve outcomes among patients in intensive-care units have produced mixed results.

Controversial Treatment May Not Help MS Patients

TUESDAY, Oct. 8 (HealthDay News) -- A theory claiming that multiple sclerosis (MS) is caused by the narrowing of veins in the neck appears to be unfounded, Canadian researchers report.

Do Breast Implants Boost Women's Sex Lives?

WEDNESDAY, Oct. 9 (HealthDay News) -- Women who got breast implants said the surgery spiced up their sex lives, a small, preliminary study found.

Health Highlights: Oct. 9, 2013

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

State-Run Health Exchanges Off to Smoother Start: Report

WEDNESDAY, Oct. 9 (HealthDay News) -- Unlike the highly publicized problems that have plagued the federal health exchange website created to help Americans register for insurance coverage, many state-run exchanges are operating well, according to published reports.

Adempas Approved to Treat Pulmonary Hypertension

WEDNESDAY, Oct. 9 (HealthDay News) -- Adempas (riociguat) has been approved by the U.S. Food and Drug Administration to treat two types of pulmonary hypertension, characterized by high blood pressure in the arteries of the lungs.